Evaluating only BioData Solutions’s profile at its peak — without knowing the outcome — the model ranked Competition as the #1 likely cause. Documented cause: Unit economics.
Key Events Timeline
FOUNDING
BioData Solutions founded to offer affordable cloud LIMS to mid-market biotech companies at $299/month.
FUNDING
Raises $5M seed; grows to 80 paying customers primarily among Series A/B biotech startups.
LAYOFF
COVID-19 disrupts biotech funding; 30% of customer base fails to renew as their own runway expires.
SHUTDOWN
Unable to replace churned revenue; company burns through cash reserves and ceases operations without formal announcement.
Full Analysis
Free · no account needed
Documented cause
BioData Solutions, founded in 2016, raised $5M to provide mid-market biotech companies with affordable cloud LIMS and research data management tools. The company's $299/month pricing undercut enterprise incumbents but failed to support adequate customer success coverage. High churn rates among small biotech clients who ran out of funding — particularly after COVID-19 disrupted biotech fundraising in 2020 — accelerated revenue decline. By 2021, the company ceased operations after burning through reserves with no viable path to Series A.
Lesson
“Selling LIMS to early-stage biotech creates a revenue base that evaporates whenever the funding market tightens.”